Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Krug, L.M; Miller, V.A; Crapanzano, J.P; Zakowski, M.F; Ng, K.K; Heelan, R.T; Ross, J; Sheehan, C; Venkatraman, E; Pizzo, B.A; McClean, N.A; Kris, M.G

• Book ID: 118569731
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 118 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80186-5